AstraZeneca returns to sales growth, led by cancer medicines

Strong demand for AstraZeneca's new drugs - especially those for cancer - drove a return to sales growth in the third quarter and the drugmaker said it now expected a period of sustained growth "for years to come".

https://ift.tt/2QtlQec support@endlesssupplies.biz (Endless Supplies .Biz) November 08, 2018 at 01:52AM